ERBB2 and neoplasm: Notably, ERBB2 amplification causes the overexpression of tyrosine kinase receptor HER2, which triggers the downstream hyperactivation of PI3K/AKT and mitogen-activated protein kinase (MAPK) pathways and which results in tumor cells proliferation and survival.